EULAR 2025 Congress Recognizes Dr. Tesser and AARA Clinical Research with Abstract Award, New RA Treatment on the Horizon

The European Alliance of Associations for Rheumatology (EULAR) has awarded Dr. John R. P. Tesser, MD, FACP, FACR, MACR, and AARA Clinical Research with an Abstract Award in the category of Clinical Research.

The seminal abstract recognized with this achievement summarizes the test of a potential new treatment for rheumatoid arthritis (RA) that utilizes an implantable device to stimulate the vagus nerve with the goal of reducing inflammation and joint pain for participants whose RA has not improved with traditional medications—bDMARDs and tsDMARDs.

Tracking the improvement of RA symptoms by at least 20% (ACR20), results from the double-blind study proved statistically significant with 35.2% of participants in the treatment group reaching the desired endpoint versus 24.2% of participants in the control group after 12 weeks. Rates of improvement for participants with only one prior exposure to bDMARDs was nearly double that of the control group at 44.2%.

Click here to learn more about the study and its pivotal impact on the future treatment of RA!